BCR and aneurysmal bone cyst: Moreover, upregulation of BCR pathway components in ABC EVs suggests it to be a potential target for therapy since the loss of B-cell receptor (BCR)- and phosphatidylinositol 3-kinase (PI3K)-activating proteins enhanced sensitivity.